Browse By Region
Browse By Category
Recent News
By Category: Biotechnology
Naval Research Lab Develops Nanofibers for Chemical and Biological Decontamination
Chemical and biological threats pose a significant concern not only to the modern warfighter but an ever-increasing number of individuals and groups. This threat is compounded by the persistence of these agents and the possibilities of causing increased personnel exposure … Continue reading →
- March 28, 2013
- | Filed under Biotechnology
Synchrotron yields ‘safer’ vaccine – BBC News
BBC NewsSynchrotron yields 'safer' vaccineBBC News"This technology has great potential in terms of cost and biosafety. "Any design strategy that minimises the chances of accidental virus release would not only make the world a safer place but would lower the bio-containment barriers to production …and more »
- March 27, 2013
- | Filed under Biotechnology
Synchrotron yields ‘safer’ vaccine – BBC News
BBC NewsSynchrotron yields 'safer' vaccineBBC News"This technology has great potential in terms of cost and biosafety. "Any design strategy that minimises the chances of accidental virus release would not only make the world a safer place but would lower the bio-containment barriers to production …and more »
- March 27, 2013
- | Filed under Biotechnology
Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013
(Marketwire) Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, provided an update to investors on the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA). The bill was signed into law today Read More »
- March 14, 2013
- | Filed under North America, Biotechnology, and Policy & Initiatives
Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013
MISSION VIEJO, CA–(Marketwire – Mar 14, 2013) – Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)
- March 14, 2013
- | Filed under Biotechnology